Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Current Period Unaudited)

v3.25.3
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 127,677,360 $ 45,816,289
Investments 15,998,427 14,395,913
Other current assets 414,825 78,869
Total current assets 144,090,612 60,291,071
Operating lease right-of-use asset 106,666 0
Total assets 144,197,278 60,291,071
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 2,568,549 2,254,300
In-process R and D accrued expenses 0 3,000,000
Total current liabilities 2,568,549 5,254,300
Operating lease liability - non-current 70,881 0
Total liabilities 2,639,430 5,254,300
Commitments and contingencies (Note 8)
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 6,662,930 and 6,102,560 shares issued and outstanding at September 30, 2025, and December 31, 2024, respectively** [1] 6,663 6,103
Additional paid-in capital 225,848,222 130,787,312
Accumulated other comprehensive income 11,698 35,992
Accumulated deficit (84,308,735) (75,792,636)
Total stockholders’ equity 141,557,848 55,036,771
Total liabilities and stockholders’ equity $ 144,197,278 $ 60,291,071
[1] Information pertaining to number of shares outstanding and per share data gives retroactive effect to a 1 for 5 reverse stock split that became effective on August 12, 2024.